Mylan/Biocon Herceptin biosimilar faces EU delay
EU inspectors require re-inspection of Bangalore plant.
X
Mylan/Biocon Herceptin biosimilar faces EU delay
https://pharmaphorum.com/news/mylanbiocon-herceptin-biosimilar-faces-eu-delay/
Biocon
Mylan expects first US Herceptin biosimilar launch
Deal with Roche paves way for near-copy of breast cancer blockbuster
Mylan and Biocon file Herceptin biosimilar in Europe
First Herceptin biosimilar filed in EU, companies say.
1 2